Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ivosidenib
ivosidenib
Agios Pharma's Tibsovo Shows Positive Results in Phase III for Another Cancer Indication
BioSpace
Thu, 05/16/19 - 06:44 pm
Agios Pharmaceuticals
Tibsovo
ivosidenib
clinical trials
cholangiocarcinoma
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Endpoints
Thu, 11/2/17 - 09:56 am
Agios Pharmaceuticals
ASH
FDA
IDH1
ivosidenib